Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective

by Cristina Hernando, Belén Ortega-Morillo, Marta Tapia, Santiago Moragón, María Teresa Martínez, Pilar Eroles, Iris Garrido-Cano, Anna Adam-Artigues, Ana Lluch, Begoña Bermejo, Juan Miguel Cejalvo
Published 2021-07-01

Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer

by Iris Garrido-Cano, Vera Constâncio, Anna Adam-Artigues, Ana Lameirinhas, Soraya Simón, Belen Ortega, María Teresa Martínez, Cristina Hernando, Begoña Bermejo, Ana Lluch, Paula Lopes, Rui Henrique, Carmen Jerónimo, Juan Miguel Cejalvo, Pilar Eroles
Published 2020-10-01

Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer

by Anna Adam-Artigues, Iris Garrido-Cano, Juan Antonio Carbonell-Asins, Ana Lameirinhas, Soraya Simón, Belén Ortega-Morillo, María Teresa Martínez, Cristina Hernando, Vera Constâncio, Octavio Burgues, Begoña Bermejo, Rui Henrique, Ana Lluch, Carmen Jerónimo, Pilar Eroles, Juan Miguel Cejalvo
Published 2021-06-01

MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma

by Birlipta Pattanayak, Iris Garrido-Cano, Anna Adam-Artigues, Eduardo Tormo, Eduardo Tormo, Begoña Pineda, Begoña Pineda, Begoña Pineda, Paula Cabello, Elisa Alonso, Elisa Alonso, Begoña Bermejo, Begoña Bermejo, Begoña Bermejo, Cristina Hernando, Cristina Hernando, María Teresa Martínez, María Teresa Martínez, Ana Rovira, Ana Rovira, Joan Albanell, Joan Albanell, Joan Albanell, Federico Rojo, Federico Rojo, Octavio Burgués, Octavio Burgués, Juan Miguel Cejalvo, Juan Miguel Cejalvo, Ana Lluch, Ana Lluch, Ana Lluch, Ana Lluch, Pilar Eroles, Pilar Eroles, Pilar Eroles
Published 2020-09-01